236 related articles for article (PubMed ID: 20956475)
1. PET of tumor CXCR4 expression with 4-18F-T140.
Jacobson O; Weiss ID; Kiesewetter DO; Farber JM; Chen X
J Nucl Med; 2010 Nov; 51(11):1796-804. PubMed ID: 20956475
[TBL] [Abstract][Full Text] [Related]
2. Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.
Zhang XX; Sun Z; Guo J; Wang Z; Wu C; Niu G; Ma Y; Kiesewetter DO; Chen X
Mol Imaging Biol; 2013 Dec; 15(6):758-67. PubMed ID: 23636490
[TBL] [Abstract][Full Text] [Related]
3. Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression.
Yan X; Niu G; Wang Z; Yang X; Kiesewetter DO; Jacobson O; Shen B; Chen X
Mol Imaging Biol; 2016 Feb; 18(1):135-42. PubMed ID: 26126597
[TBL] [Abstract][Full Text] [Related]
4. Improvement of CXCR4 tracer specificity for PET imaging.
Jacobson O; Weiss ID; Szajek LP; Niu G; Ma Y; Kiesewetter DO; Peled A; Eden HS; Farber JM; Chen X
J Control Release; 2012 Jan; 157(2):216-23. PubMed ID: 21964282
[TBL] [Abstract][Full Text] [Related]
5. High-Contrast CXCR4-Targeted
Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
[TBL] [Abstract][Full Text] [Related]
6. [
Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
[TBL] [Abstract][Full Text] [Related]
7. Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid
Basuli F; Zhang X; Phelps TE; Jagoda EM; Choyke PL; Swenson RE
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867358
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of CXCR4 using copper-64 labeled peptide antagonist.
Jacobson O; Weiss ID; Szajek LP; Niu G; Ma Y; Kiesewetter DO; Farber JM; Chen X
Theranostics; 2011; 1():251-62. PubMed ID: 21544263
[TBL] [Abstract][Full Text] [Related]
9. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
11. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
[TBL] [Abstract][Full Text] [Related]
12. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A
J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.
Demoin DW; Shindo M; Zhang H; Edwards KJ; Serganova I; Pillarsetty NV; Lewis JS; Blasberg RG
Nucl Med Biol; 2016 Oct; 43(10):606-11. PubMed ID: 27485481
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biologic Evaluation of a Novel
Donnelly DJ; Smith RA; Morin P; Lipovšek D; Gokemeijer J; Cohen D; Lafont V; Tran T; Cole EL; Wright M; Kim J; Pena A; Kukral D; Dischino DD; Chow P; Gan J; Adelakun O; Wang XT; Cao K; Leung D; Bonacorsi SJ; Hayes W
J Nucl Med; 2018 Mar; 59(3):529-535. PubMed ID: 29025984
[TBL] [Abstract][Full Text] [Related]
16. Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent.
Tamamura H; Fujisawa M; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
FEBS Lett; 2004 Jul; 569(1-3):99-104. PubMed ID: 15225616
[TBL] [Abstract][Full Text] [Related]
17. [
Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]